User contributions
For
(newest | oldest) View (newer 100 | older 100) (20 | 50 | 100 | 250 | 500)
- 18:40, 20 April 2017 (diff | hist) . . (-22) . . Information on nutritional supplements people with ALS have been taking
- 18:23, 20 April 2017 (diff | hist) . . (-4) . . Information on nutritional supplements people with ALS have been taking
- 18:20, 20 April 2017 (diff | hist) . . (+4) . . Information on nutritional supplements people with ALS have been taking
- 17:59, 20 April 2017 (diff | hist) . . (+22) . . Information on nutritional supplements people with ALS have been taking
- 17:41, 20 April 2017 (diff | hist) . . (+2) . . Mitochondrial dysfunction
- 17:40, 20 April 2017 (diff | hist) . . (+25) . . Mitochondrial dysfunction
- 17:38, 20 April 2017 (diff | hist) . . (+201) . . N CommentStreams:E65f5a34878d5e3d9071c9d6c25cce3e (current)
- 17:34, 20 April 2017 (diff | hist) . . (+85) . . N Mitochondrial dysfunction (Created page with "Information can be sourced from the discussion thread mentioned in the comment below.")
- 15:49, 20 April 2017 (diff | hist) . . (+3) . . Main Page
- 15:25, 20 April 2017 (diff | hist) . . (+1,007) . . Hypoxia
- 14:29, 20 April 2017 (diff | hist) . . (+7) . . Hypoxia
- 14:28, 20 April 2017 (diff | hist) . . (+6) . . Hypoxia
- 14:26, 20 April 2017 (diff | hist) . . (+1,463) . . Hypoxia
- 14:17, 20 April 2017 (diff | hist) . . (+182) . . N Talk:Information on nutritional supplements people with ALS have been taking (Created page with "Since this is a list of ''supplements'', such prescription drugs as lithium and valproate are not included, although they are used by some PALS and have some evidence in their...")
- 09:47, 20 April 2017 (diff | hist) . . (+197) . . N CommentStreams:F18ca9cec4cb7827861842e3cf4beab8 (current)
- 09:39, 20 April 2017 (diff | hist) . . (+160) . . N Hypoxia (Created page with " A hypothesis that some forms of ALS involve a metabolic shift from oxidative phosphorylation towards glycolysis, similar to the Warburg effect in cancer cells.")
- 18:49, 19 April 2017 (diff | hist) . . (+8) . . Alcohol
- 18:44, 19 April 2017 (diff | hist) . . (+907) . . Alcohol
- 18:18, 19 April 2017 (diff | hist) . . (+379) . . Alcohol
- 16:05, 19 April 2017 (diff | hist) . . (+21) . . ER stress
- 16:00, 19 April 2017 (diff | hist) . . (+1,823) . . N ER stress (Created page with " '''Alpha-motoneurons and muscle fibres are structurally and functionally interdependent. Both cell types particularly rely on endoplasmic reticulum (ER/SR) functions. Mutati...")
- 14:48, 19 April 2017 (diff | hist) . . (+4) . . MediaWiki:Common.css
- 14:47, 19 April 2017 (diff | hist) . . (-4) . . MediaWiki:Common.css
- 14:25, 19 April 2017 (diff | hist) . . (+4) . . MediaWiki:Common.css
- 14:21, 19 April 2017 (diff | hist) . . (+48) . . MediaWiki:Common.css
- 12:30, 19 April 2017 (diff | hist) . . (+41) . . MediaWiki:Common.css
- 10:26, 19 April 2017 (diff | hist) . . (+47) . . Information on nutritional supplements people with ALS have been taking
- 10:19, 19 April 2017 (diff | hist) . . (+29) . . Supplements listed by their effects
- 09:49, 19 April 2017 (diff | hist) . . (+22) . . CommentStreams:08388edcab3f1986d5eaa3cb679da386 (current)
- 09:44, 19 April 2017 (diff | hist) . . (+324) . . N CommentStreams:08388edcab3f1986d5eaa3cb679da386
- 21:29, 18 April 2017 (diff | hist) . . (0) . . MediaWiki:Common.css
- 21:15, 18 April 2017 (diff | hist) . . (-4) . . MediaWiki:Common.css
- 20:59, 18 April 2017 (diff | hist) . . (+67) . . MediaWiki:Common.css
- 20:22, 18 April 2017 (diff | hist) . . (+4) . . MediaWiki:Common.css
- 20:17, 18 April 2017 (diff | hist) . . (+78) . . N MediaWiki:Common.css (Created page with "→CSS placed here will be applied to all skins: * {font-family: open sans}")
- 18:16, 18 April 2017 (diff | hist) . . (+21) . . User:Admin
- 18:13, 18 April 2017 (diff | hist) . . (0) . . N File:Profil.jpg (current)
- 17:27, 18 April 2017 (diff | hist) . . (+3) . . User:Admin
- 17:26, 18 April 2017 (diff | hist) . . (+168) . . N User:Admin (Created page with "Riku Mattila ALS onset 2010, diagnosis 12/2012. Completely paralyzed, using computer with the Tobii PCEyeGo. Member of the board at [http://alstuttu.org/ alstuttu.org].")
- 17:16, 18 April 2017 (diff | hist) . . (+113) . . N CommentStreams:10632494015157221025e52bbde31fe1 (current)
- 15:35, 18 April 2017 (diff | hist) . . (+346) . . N CommentStreams:A067aad6b8c7bd3c0287eb5ce44bc0d5 (current)
- 11:38, 17 April 2017 (diff | hist) . . (-3,818) . . Ashwagandha
- 11:34, 17 April 2017 (diff | hist) . . (+32) . . Ashwagandha
- 11:23, 17 April 2017 (diff | hist) . . (+28) . . Ashwagandha
- 11:12, 17 April 2017 (diff | hist) . . (+38) . . Ashwagandha
- 11:09, 17 April 2017 (diff | hist) . . (-4) . . Acetyl L-carnitine (ALCAR)
- 10:54, 17 April 2017 (diff | hist) . . (-5,263) . . Acetyl L-carnitine (ALCAR)
- 10:23, 17 April 2017 (diff | hist) . . (-4,302) . . Acetyl L-carnitine (ALCAR)
- 10:09, 17 April 2017 (diff | hist) . . (-4,177) . . Acetyl L-carnitine (ALCAR)
- 08:48, 17 April 2017 (diff | hist) . . (-2,904) . . Acetyl L-carnitine (ALCAR)
- 08:41, 17 April 2017 (diff | hist) . . (-1,931) . . Acetyl L-carnitine (ALCAR)
- 08:36, 17 April 2017 (diff | hist) . . (-1,914) . . Acetyl L-carnitine (ALCAR)
- 08:05, 17 April 2017 (diff | hist) . . (-5,686) . . Acetyl L-carnitine (ALCAR)
- 07:20, 17 April 2017 (diff | hist) . . (-4,676) . . Acetyl L-carnitine (ALCAR)
- 07:03, 17 April 2017 (diff | hist) . . (+85) . . Acetyl L-carnitine (ALCAR)
- 06:13, 17 April 2017 (diff | hist) . . (-12,433) . . 5-HTP
- 06:10, 17 April 2017 (diff | hist) . . (+58) . . 5-HTP
- 22:18, 16 April 2017 (diff | hist) . . (+36) . . 5-HTP
- 22:04, 16 April 2017 (diff | hist) . . (+26) . . 5-HTP
- 21:57, 16 April 2017 (diff | hist) . . (+163) . . N Category:Supplement data pages (Created page with "A separate page will be written for each substance, with data collected from different reliable sources. It is important that references are included for all data.")
- 21:49, 16 April 2017 (diff | hist) . . (+36) . . 5-HTP
- 18:49, 16 April 2017 (diff | hist) . . (+96) . . N Category:Supplement summary (Created page with "A summary table of the information found in more detail in data pages for individual substances.") (current)
- 18:41, 16 April 2017 (diff | hist) . . (+33) . . Information on nutritional supplements people with ALS have been taking
- 13:00, 16 April 2017 (diff | hist) . . (+23) . . Ammonium hypothesis
- 12:56, 16 April 2017 (diff | hist) . . (+169) . . N Ammonium hypothesis (Created page with " Bhavin Parekh has presented a hypothesis that some forms of ALS could be caused by chronic excess ammonia in the body. {{#pmid:27785351|parekh2015}} == References ==")
- 19:01, 14 February 2017 (diff | hist) . . (+377) . . Calcium homeostasis
- 17:53, 14 February 2017 (diff | hist) . . (+6) . . Calcium homeostasis
- 17:52, 14 February 2017 (diff | hist) . . (+810) . . N Calcium homeostasis (Created page with "''The major mechanisms contributing to the degeneration of motor neurons have already been disclosed and characterized, including excitotoxicity, oxidative stress, mitochondri...")
- 12:22, 14 February 2017 (diff | hist) . . (+79) . . Information on nutritional supplements people with ALS have been taking
- 12:17, 14 February 2017 (diff | hist) . . (+40) . . Information on nutritional supplements people with ALS have been taking
- 21:28, 13 February 2017 (diff | hist) . . (+1,797) . . Methylcobalamin
- 20:48, 13 February 2017 (diff | hist) . . (+686) . . N Vitamin D3 (Created page with " == ALSUntangled evaluation == ''At this time, there is evidence that PALS, like those with other chronic illnesses, are at increased risk for vitamin D deficiency. It is the...")
- 16:36, 13 February 2017 (diff | hist) . . (+577) . . Nerves that resist destruction
- 16:25, 13 February 2017 (diff | hist) . . (+40) . . Key concepts in ALS
- 16:03, 13 February 2017 (diff | hist) . . (-15,378) . . Inosine
- 16:01, 13 February 2017 (diff | hist) . . (+25) . . Inosine
- 15:56, 13 February 2017 (diff | hist) . . (+21) . . Inosine
- 15:52, 13 February 2017 (diff | hist) . . (+23) . . Inosine
- 15:48, 13 February 2017 (diff | hist) . . (+28) . . Inosine
- 15:44, 13 February 2017 (diff | hist) . . (+31) . . Inosine
- 15:40, 13 February 2017 (diff | hist) . . (+33) . . Inosine
- 15:33, 13 February 2017 (diff | hist) . . (+516) . . Inosine
- 15:22, 13 February 2017 (diff | hist) . . (+392) . . MitoQ
- 15:16, 13 February 2017 (diff | hist) . . (+125) . . N MitoQ (Created page with "Information on nutritional supplements people with ALS have been taking == ALSUntangled evaluation == == References ==")
- 15:14, 13 February 2017 (diff | hist) . . (+76) . . Spirulina
- 15:09, 13 February 2017 (diff | hist) . . (-10,227) . . Luteolin
- 14:21, 13 February 2017 (diff | hist) . . (+26) . . Luteolin
- 13:55, 13 February 2017 (diff | hist) . . (+33) . . Luteolin
- 13:48, 13 February 2017 (diff | hist) . . (+844) . . Luteolin
- 13:34, 13 February 2017 (diff | hist) . . (+388) . . N Spirulina (Created page with " == ALSUntangled evaluation == ''At this time, ALSuntangled finds no evidence that Spirulina is effective for ALS and there appear to be real and theoretical toxicities that...")
- 13:12, 13 February 2017 (diff | hist) . . (+23) . . Key concepts in ALS
- 13:10, 13 February 2017 (diff | hist) . . (+24) . . Neuroinflammation
- 13:07, 13 February 2017 (diff | hist) . . (+995) . . N Neuroinflammation (Created page with " ''Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and frontotemporal lobar dementia are among the most pressing pr...")
- 11:50, 13 February 2017 (diff | hist) . . (+36) . . Loss of BBB integrity
- 11:31, 13 February 2017 (diff | hist) . . (+1,696) . . Loss of BBB integrity
- 10:11, 13 February 2017 (diff | hist) . . (+1,248) . . N Loss of BBB integrity (Created page with " ''Vascular pathology, including blood-brain/spinal cord barrier (BBB/BSCB) alterations, has recently been recognized as a key factor possibly aggravating motor neuron damage,...")
- 21:46, 12 February 2017 (diff | hist) . . (+2,315) . . Aberrant astrocytes
- 21:38, 12 February 2017 (diff | hist) . . (+22) . . Key concepts in ALS
- 21:32, 12 February 2017 (diff | hist) . . (+7) . . Aberrant astrocytes
- 21:26, 12 February 2017 (diff | hist) . . (+1,601) . . Aberrant astrocytes
(newest | oldest) View (newer 100 | older 100) (20 | 50 | 100 | 250 | 500)